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Background: The presence of cranial autonomic symptoms often leads to a misdiagnosis of sinus headache or ocular 
problems in adult migraineurs, leading to unnecessary investigations &delaying treatment.Objective: This study was 
done todetermine the frequency of cranial autonomic symptoms (CAS) among migraine patients presenting to 
neurology ward of tertiary care hospital in Karachi.METHODS: This descriptive cross sectional studywas conducted in 
duration of one year in Neurology Ward Jinnah Postgraduate Medical Center, Karachi. Total 105 patients of age 18-65 
years, either gender, diagnosed cases of migraine of >1 year duration were consecutively selected.RESULTS: Mean 
± SD age was 35.08 ± 10.18 years. Mean ± SD duration of migraine at was 3.68 ± 1.42 years. Majority of patients 
were females i-e; 59% (n=62). Frequency of CAS was more (75.8%) in patients of 21-40 years age compared to elder 
and very younger age patients (P value = 0.303). Female patients had very higher incidence of CAS (77.4%) 
compared to their male (P value < 0.049). Frequency of CAS was 58.82% with history of up to 1 year of migraine, 
68.18% with history of 2-3 years & 74.24% with 4-5 years history of migraine. (P value 0.002).CONCLUSION: The 
CAS in migraine patients are very frequently present. All migraine patients should be evaluated for cranial autonomic 
symptoms from the day one of their diagnosis. 
KEY WORDS:  Migraine,Cranial autonomic symptoms.
O R I G I N A L  A R T I C L E
INTRODUCTION
Of all the painful states that afflict humans, headache 
is undoubtedly the most frequent and common reason 
for seeking medical help. Headache has over 300 
different types and different etiologies; migraine is one 
of them and continues being an under diagnosed 
condition in many of cases as it can be accompanied 
by symptoms commonly associated with other causes 
of facial pain.  Out of 28 million people in USA who 
have history of headache and symptoms which mimic 
the typical migraine only 48% are diagnosed of 
migraine.  In Pakistan the prevalenceof migraine was 
found to be around 30%. ,  and about twice as 
frequently in women as in men5. Migraine headaches, 
which are often, misdiagnosed as sinus or tension 
headaches affects work, social and leisure activities & 
has tremendous impact on a person’s life 6 .WHO in 
2004 released a report placing migraine on 19th rank 
with which migraine sufferers live years of their life with 
disability. 7These may occur as often as several times 
per week oras rarely as once or twice a year8.Cranial 
autonomic symptoms (CAS) are typically associated 
with trigeminal autonomic cephalgias, such as cluster 
headache 9. However they may also occur in patients 
with migraine. The frequency of symptoms is reported 
to vary widely from 27% to 73% in different studies. 
10,11,12 Recognition of CAS as a common 
component of migraine is important diagnostically and 
thus therapeutically. In a study conducted on pediatric 
patients, nearly 40% 13 and in another study 
conducted on adult patients it was found that 52% 
were initially mislabeled as having sinus related 
headaches 14.The international Classification of 
Headache Disorders, second edition 
(ICHD-II)15includes conjuctival injection, lacrimation 
(or both), nasal congestion, rhinorrhea (or both), eyelid 
edema, forehead and facial sweating, forehead/facial 
flushing and/or miosis& ptosis .In ICHD-III, a sense of 
aural fullness will be added as a cranial autonomic 
symptom.16. The international studies have 
documented variability in prevalence of CAS among 
migraine patients however no study was done at local 
level. The current study has evaluated and measured 
the burden of CAS among migraine patients in tertiary 
care hospital. Failure to recognize which, may lead to 
unnecessary investigations and delaying appropriate 
migraine therapy.
MATERIAL AND METHODS
This was a descriptive cross sectional study carried out 
in Neurology department JinnahPostgraduate Medical 
Center, Karachi from 1stJanuary 2015 to 31stt 
December 2015. Estimated prevalence of CAS among 
migraine patients taken at rate of 15.6%12, margin of 
error 7%, & level of significance 95% and using WHO’s 
sample size calculator the calculated sample size 
came was 103 ~ 105.Non probability consecutive 
sampling technique was used to select 
sample.Informed consent was taken from the patients 
and purpose of study was explained to them. 
Diagnosed cases of migraine for at least >1 year, of 
either gender with age between 18 to 60 years and 
ready to participate in the study were included.Patients 
fulfilling criteria for Trigeminal autonomic cephalalgias, 
tension type headache, head injury, bell’s palsy, space 
occupying lesion of brain ,patients suffering from 
autonomic neuropathy due to diabetes mellitus, , 
glaucoma, uveitis, recent ophthalmological and ENT 
surgery andpatients having symptoms of allergic 
rhinitisand nasal obstructive symptoms were excluded 
from the study.Permission for the data collection was 
taken from Ethical committee of JPMC.The researcher 
collected data on a predesigned pro forma including 
demographic variables like name, age, gender 
andresidence,further data regarding presence of CAS 
(conjuctival injection, lacrimation, nasal congestion, 
rhinorrhea, eyelid edema, forehead/facial sweating, 
forehead/facial flushing and miosis or ptosis) were also 
collected.The data entry and analysis was done using 
SPSS version 19. Mean ± SD was expressed for 
continuous variable like age, duration of disease & 
duration of migraine attack. Frequency & percentages 
were expressed for gender & residence (rural or urban), 
number of attacks of migraine & presence of CAS. The 
effect modification of outcome variable (frequency of 
CAS) due to age, gender, & duration of diseasewere 
analyzed by stratification of these variables followed by 
application of the chi-Square test with a P value 
significance of <0.05. Selection criteria were strictly 
followed to control for the potential confounders.
 
RESULTS
The current study assessed the frequency of cranial 
autonomic symptoms among migraine headache 
patients. Mean ± SD age of patients was 35.08 ± 
10.18 years with a range from 19-60 years. Mean ± 
SD duration of migraineat time of presentation was 
3.68 ± 1.42 years & minimum & maximum durations 
were 01 &05years respectively. (Table1). 
Table: 1. Basic characteristics. (n= 105)
Further it was noted that mean ± SD duration of 
attack of migraine headache was 25.14 ± 9.89 hours 
with the range of 4 to 72 hours. (Table1).It was 
observed that nearly two third of the patients (62.86%, 
n=66) were of 21-40 years of age, (29.52%, n = 31) 
were of age 41-60 years while remaining 7.62% (n= 
8) were of age upto 20 years. Majority of patients were 
females i-e; 59% (n=62).Equal distribution was noted 
as far as residence was concerned. Urban residents 
were 49.5% (n= 52).Majority of patients (62.9%, 
n=66) had history of migraine for 4-5 years, other 
21%, (n= 22) had migraine for 2-3 years while only 
16.2% (n= 17) patients presented with upto 1 year 
history of migraine.Frequency of cranial autonomic 
symptoms (CAS) in migraine patients (the primary 
outcome) were detected among 70.48% (n= 74 out 
of 105). (Figure1) and forehead/facial sweating was 
most common symptom. (Table:2)
Figure: 1. Frequency of cranial autonomic symptoms 
in Migraine patients. (n=105)
Table: 2. Frequency of different cranial autonomic 
symptoms.
To evaluate the effect modification of outcome variable 
by other variables we conducted the stratified analysis. 
It was found in this analysis that frequency of cranial 
autonomic symptoms (CAS) was more (75.8%) in 
patients of 21-40 years age compared to elder and 
very younger age patients (i-e; 61.3% in 41-60 years 
age group &62.5% in upto 20 years age group). (P 
value = 0.303; Table: 3).
Table: 3 Effect of age on frequency cranial autonomic 
symptoms in Migraine patients.
It was significantly noted that female patients had very 
higher incidence of CAS (77.4%) compared to their 
male counterparts (60.5%). (P value < 0.049; Table: 
4).
Table: 4. Effect of genderon frequency cranial 
autonomic symptoms in Migraine patients.
Residence showed only minimal difference and urban 
patients had 71.2%frequency of CAS compared to 
69.8% among rural patients. (P value 
0.525).However; it was worth noting that longer the 
duration of disease, higher was the frequency of 
cranial autonomic symptoms (CAS) and the finding 
was significant. (P value 0.002). The frequency of CAS 
was 58.82% among patients with history of upto 1 
year duration of migraine, 68.18% among patient with 
history of 2-3 years&74.24% among 4-5 years history 
of migraine.
DISCUSSION
Migraineis a common and disablingneurological 
disorder.17,18.Daily many patients in our neurology 
OPD present with episodic severe throbbing headache 
which is diagnosed as migraine. It is characterized by 
recurrent attacks of headache and combinations of 
neurologic, gastrointestinal, and autonomic changes. 
Unilateral cranial autonomic symptoms (UAS) are 
features of cluster headache, paroxysmal hemicrania, 
and SUNCT.2,9,12,17Studies have found an 
association between cranial autonomic symptoms and 
migraineattack, hypothesizing possiblepathogenesis 
10,12,19.On the basis of these considerations 
andonsuggestionofacranial parasympathetic activation 
in some migraineurs, we evaluated the frequency of 
cranial autonomic symptoms during cephalalgic 
attacks in patients presenting to our institute with the 
symptoms of migraine.Our study shows that in 
migraineurs, cranial autonomic symptoms are 
common. It was found that incidence of cranial 
autonomic symptoms (CAS) in migraine patients was 
70.48%.Our results are correlating with similar results 
of other studies. However; the incidence of CAS 
reported by various studies range from 27% to 
73%7,10,12,20,21,22. Our study did not include the 
pediatric patients. But in a recentstudy23high 
frequency of cranial autonomic symptoms was found in 
pediatric migraineurs(i-e; 62%, which canrise to 
70%with inclusion of new proposed International 
Headache Society criteria)16. We have not used the 
new proposed International Headache Society criteria 
otherwise the incidence rate might have been found at 
least 10% more.In a prospective study conducted on 
migraine patients, the prevalence of >1 CAS was 
56%17. Likewise; in the current study we noted that 
about 52% patients had >1 CAS e.g; forehead/ facial 
sweating, lacrimation, nasal congestion, conjunctival 
injection, rhinorrhea, and eyelid edema. Presence of 
more than one CAS in migraine patients clearly directs 
its association with cranial autonomic symptoms. Lai 
TH, et al., reported that among migraine patients with 
CAS, forehead/ facial sweating was the most common 
(51.7%) followed by lacrimation (44.2%), nasal 
congestion (25.2%), conjunctival injection (23.8%), 
rhinorrhea (21.5%), and eyelid edema (15.6%)9.The 
current study found very similar pattern but the 
incidence of these symptoms was lesser. Accordingly; 
forehead/ facial sweating was the most common 
(41%) followed by lacrimation (31.4%), nasal 
congestion (24.8%), conjunctival injection (21.9%). 
Similarly; one study found that unilateral cranial 
autonomic symptoms occurred during migraine attacks 
in 81 patients (45.8%); during attacks, ocular 
symptoms (conjunctival injection, lacrimation, or eyelid 
edema) occurred alone in 33 patients and in 
combination with nasal symptoms (nasal stuffiness or 
rhinorrhea) in 37 patients. Isolated nasal symptoms 
occurred in 11 patients. Other studies from other 
populations have documented varying frequencies of 
these symptoms in migraine patients.10,12,24,25 
Mean age of our patients was 35 years however; very 
young age i-e; 19 years old patients were also included 
&nearly two third patients (62.86%, n=66) were of 
21-40 years. These findings do not match with other 
studies which is due to the fact that migraine is 
prevalent in all age groups & different studies focus 
different age groups11,18,21,26,.We had taken only 
the adult patients. Other demographic feature of our 
patients was the gender distribution. We noted that 
majority of patients were females i-e; 59% that agrees 
with findings of previous researchers 10,11,20,22But; 
in the current study, the stratified analysis significantly 
showed that the female patients had very higher 
incidence of CAS (77.4%) compared to their male 
counterparts (60.5%). (P value < 0.049).  Regarding 
age the stratified analysis significantly showed that 
middle aged (21-40 years) patients had higher 
frequency of cranial autonomic symptomscompared to 
elder and very younger age patients (P value = 
0.303).Living in a rural or urban setting was also 
doubted to be an effect modifier but the current study 
ruled out it and found that residence showed only 
minimal difference as the urban living patients had 
CAS incidence of 71.2%compared to 69.8% in rural 
patients. (P value = 0.525).One important aspect of 
this study was evaluation of duration of migraine since 
its diagnosis and look for its association with 
incidenceof cranial autonomic symptoms in our 
patients. We hereby document that it was a significant 
finding in our analysis that longer the duration of 
disease, higher was the frequency of CAS. (P value 
0.002). Studies have documented that the patients 
with unilateral cranial autonomic symptomspresent 
with more severe headaches (P value <0.0002) and 
more strictly unilateral headaches (P value <0.0004) 
than those without unilateral cranial autonomic 
symptoms, findings that suggest trigeminal-autonomic 
reflex activation.10 Apart from that it has been 
suggested that a general autonomic hyperactivity 
(especiallyparasympathetic) may also be found more 
frequent in different populations of CAS–positive 
migraineurscompared to  CAS negative 
migraineurs5,8,15 but exploring these was beyond the 
scope of the current study.Although the study was of 
limited scope due to limited financial & time resources 
and smaller sample size yet it has investigated an 
important aspect of clinical pictures of migraine 
patients. The study also found the magnitude of 
burden of cranial autonomic symptoms in such 
patients which previously had been a neglected issue 
in our part of world. The current study suggests that 
more in depth and larger studies should be conducted 
on this aspect of migraine.
 
CONCLUSION
It is evidence based fact that cranial autonomic 
symptoms (CAS) such as lacrimation, conjunctival 
injection, eyelid edema and nasal congestion, which 
are the hallmark of trigeminal autonomic cephalalgias 
may also occur in migraine patients. The current study 
evaluated the magnitude of burden of these symptoms 
in local migraine affected patients. The study found 
that the cranial autonomic symptomsin migraine 
patients are very frequently present. Forehead/ facial 
sweating, lacrimation, nasal congestion, conjunctival 
injection, rhinorrhea and eyelid edema were the 
commonest symptoms. Female gender, middle age, 
and longer duration of disease are associated with 
higher incidence of CAS. The study recommends that 
all migraine patients should be evaluated for cranial 
autonomic symptoms from the day one of their 
diagnosis.Failure to recognize CAS would lead to 
misdiagnosis or under diagnosis of a common 
treatable condition resulting in increment in patient’s 
misery. Its early recognition could have therapeutic 
implications, given the potential large scale 
recruitment of peripheral neurovascular 5-HT 1B/1D 
receptors (the target of acute migraine treatment) in 
such patients.
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INTRODUCTION
Of all the painful states that afflict humans, headache 
is undoubtedly the most frequent and common reason 
for seeking medical help. Headache has over 300 
different types and different etiologies; migraine is one 
of them and continues being an under diagnosed 
condition in many of cases as it can be accompanied 
by symptoms commonly associated with other causes 
of facial pain.  Out of 28 million people in USA who 
have history of headache and symptoms which mimic 
the typical migraine only 48% are diagnosed of 
migraine.  In Pakistan the prevalenceof migraine was 
found to be around 30%. ,  and about twice as 
frequently in women as in men5. Migraine headaches, 
which are often, misdiagnosed as sinus or tension 
headaches affects work, social and leisure activities & 
has tremendous impact on a person’s life 6 .WHO in 
2004 released a report placing migraine on 19th rank 
with which migraine sufferers live years of their life with 
disability. 7These may occur as often as several times 
per week oras rarely as once or twice a year8.Cranial 
autonomic symptoms (CAS) are typically associated 
with trigeminal autonomic cephalgias, such as cluster 
headache 9. However they may also occur in patients 
with migraine. The frequency of symptoms is reported 
to vary widely from 27% to 73% in different studies. 
10,11,12 Recognition of CAS as a common 
component of migraine is important diagnostically and 
thus therapeutically. In a study conducted on pediatric 
patients, nearly 40% 13 and in another study 
conducted on adult patients it was found that 52% 
were initially mislabeled as having sinus related 
headaches 14.The international Classification of 
Headache Disorders, second edition 
(ICHD-II)15includes conjuctival injection, lacrimation 
(or both), nasal congestion, rhinorrhea (or both), eyelid 
edema, forehead and facial sweating, forehead/facial 
flushing and/or miosis& ptosis .In ICHD-III, a sense of 
aural fullness will be added as a cranial autonomic 
symptom.16. The international studies have 
documented variability in prevalence of CAS among 
migraine patients however no study was done at local 
level. The current study has evaluated and measured 
the burden of CAS among migraine patients in tertiary 
care hospital. Failure to recognize which, may lead to 
unnecessary investigations and delaying appropriate 
migraine therapy.
MATERIAL AND METHODS
This was a descriptive cross sectional study carried out 
in Neurology department JinnahPostgraduate Medical 
Center, Karachi from 1stJanuary 2015 to 31stt 
December 2015. Estimated prevalence of CAS among 
migraine patients taken at rate of 15.6%12, margin of 
error 7%, & level of significance 95% and using WHO’s 
sample size calculator the calculated sample size 
came was 103 ~ 105.Non probability consecutive 
sampling technique was used to select 
sample.Informed consent was taken from the patients 
and purpose of study was explained to them. 
Diagnosed cases of migraine for at least >1 year, of 
either gender with age between 18 to 60 years and 
ready to participate in the study were included.Patients 
fulfilling criteria for Trigeminal autonomic cephalalgias, 
tension type headache, head injury, bell’s palsy, space 
occupying lesion of brain ,patients suffering from 
autonomic neuropathy due to diabetes mellitus, , 
glaucoma, uveitis, recent ophthalmological and ENT 
surgery andpatients having symptoms of allergic 
rhinitisand nasal obstructive symptoms were excluded 
from the study.Permission for the data collection was 
taken from Ethical committee of JPMC.The researcher 
collected data on a predesigned pro forma including 
demographic variables like name, age, gender 
andresidence,further data regarding presence of CAS 
(conjuctival injection, lacrimation, nasal congestion, 
rhinorrhea, eyelid edema, forehead/facial sweating, 
forehead/facial flushing and miosis or ptosis) were also 
collected.The data entry and analysis was done using 
SPSS version 19. Mean ± SD was expressed for 
continuous variable like age, duration of disease & 
duration of migraine attack. Frequency & percentages 
were expressed for gender & residence (rural or urban), 
number of attacks of migraine & presence of CAS. The 
effect modification of outcome variable (frequency of 
CAS) due to age, gender, & duration of diseasewere 
analyzed by stratification of these variables followed by 
application of the chi-Square test with a P value 
significance of <0.05. Selection criteria were strictly 
followed to control for the potential confounders.
 
RESULTS
The current study assessed the frequency of cranial 
autonomic symptoms among migraine headache 
patients. Mean ± SD age of patients was 35.08 ± 
10.18 years with a range from 19-60 years. Mean ± 
SD duration of migraineat time of presentation was 
3.68 ± 1.42 years & minimum & maximum durations 
were 01 &05years respectively. (Table1). 
Table: 1. Basic characteristics. (n= 105)
Further it was noted that mean ± SD duration of 
attack of migraine headache was 25.14 ± 9.89 hours 
with the range of 4 to 72 hours. (Table1).It was 
observed that nearly two third of the patients (62.86%, 
n=66) were of 21-40 years of age, (29.52%, n = 31) 
were of age 41-60 years while remaining 7.62% (n= 
8) were of age upto 20 years. Majority of patients were 
females i-e; 59% (n=62).Equal distribution was noted 
as far as residence was concerned. Urban residents 
were 49.5% (n= 52).Majority of patients (62.9%, 
n=66) had history of migraine for 4-5 years, other 
21%, (n= 22) had migraine for 2-3 years while only 
16.2% (n= 17) patients presented with upto 1 year 
history of migraine.Frequency of cranial autonomic 
symptoms (CAS) in migraine patients (the primary 
outcome) were detected among 70.48% (n= 74 out 
of 105). (Figure1) and forehead/facial sweating was 
most common symptom. (Table:2)
Figure: 1. Frequency of cranial autonomic symptoms 
in Migraine patients. (n=105)
Variable
 
Minimum
 
Maximum Mean
 
Standard 
deviation
 
Age of the
Patient
19 60 35.08 10.18 
Duration of 
Migraine 
(Years) 
1 5 3.68 1.42 
Duration of migraine
attack  
(hours) 
4 72 25.14 9.89 
 
Table: 2. Frequency of different cranial autonomic 
symptoms.
To evaluate the effect modification of outcome variable 
by other variables we conducted the stratified analysis. 
It was found in this analysis that frequency of cranial 
autonomic symptoms (CAS) was more (75.8%) in 
patients of 21-40 years age compared to elder and 
very younger age patients (i-e; 61.3% in 41-60 years 
age group &62.5% in upto 20 years age group). (P 
value = 0.303; Table: 3).
Table: 3 Effect of age on frequency cranial autonomic 
symptoms in Migraine patients.
It was significantly noted that female patients had very 
higher incidence of CAS (77.4%) compared to their 
male counterparts (60.5%). (P value < 0.049; Table: 
4).
Table: 4. Effect of genderon frequency cranial 
autonomic symptoms in Migraine patients.
Residence showed only minimal difference and urban 
patients had 71.2%frequency of CAS compared to 
69.8% among rural patients. (P value 
0.525).However; it was worth noting that longer the 
duration of disease, higher was the frequency of 
cranial autonomic symptoms (CAS) and the finding 
was significant. (P value 0.002). The frequency of CAS 
was 58.82% among patients with history of upto 1 
year duration of migraine, 68.18% among patient with 
history of 2-3 years&74.24% among 4-5 years history 
of migraine.
DISCUSSION
Migraineis a common and disablingneurological 
disorder.17,18.Daily many patients in our neurology 
OPD present with episodic severe throbbing headache 
which is diagnosed as migraine. It is characterized by 
recurrent attacks of headache and combinations of 
neurologic, gastrointestinal, and autonomic changes. 
Unilateral cranial autonomic symptoms (UAS) are 
features of cluster headache, paroxysmal hemicrania, 
and SUNCT.2,9,12,17Studies have found an 
association between cranial autonomic symptoms and 
migraineattack, hypothesizing possiblepathogenesis 
10,12,19.On the basis of these considerations 
andonsuggestionofacranial parasympathetic activation 
in some migraineurs, we evaluated the frequency of 
cranial autonomic symptoms during cephalalgic 
attacks in patients presenting to our institute with the 
symptoms of migraine.Our study shows that in 
migraineurs, cranial autonomic symptoms are 
common. It was found that incidence of cranial 
autonomic symptoms (CAS) in migraine patients was 
70.48%.Our results are correlating with similar results 
of other studies. However; the incidence of CAS 
reported by various studies range from 27% to 
73%7,10,12,20,21,22. Our study did not include the 
pediatric patients. But in a recentstudy23high 
frequency of cranial autonomic symptoms was found in 
pediatric migraineurs(i-e; 62%, which canrise to 
70%with inclusion of new proposed International 
Headache Society criteria)16. We have not used the 
new proposed International Headache Society criteria 
otherwise the incidence rate might have been found at 
least 10% more.In a prospective study conducted on 
migraine patients, the prevalence of >1 CAS was 
56%17. Likewise; in the current study we noted that 
about 52% patients had >1 CAS e.g; forehead/ facial 
sweating, lacrimation, nasal congestion, conjunctival 
injection, rhinorrhea, and eyelid edema. Presence of 
more than one CAS in migraine patients clearly directs 
its association with cranial autonomic symptoms. Lai 
TH, et al., reported that among migraine patients with 
CAS, forehead/ facial sweating was the most common 
(51.7%) followed by lacrimation (44.2%), nasal 
congestion (25.2%), conjunctival injection (23.8%), 
rhinorrhea (21.5%), and eyelid edema (15.6%)9.The 
current study found very similar pattern but the 
incidence of these symptoms was lesser. Accordingly; 
forehead/ facial sweating was the most common 
(41%) followed by lacrimation (31.4%), nasal 
congestion (24.8%), conjunctival injection (21.9%). 
Similarly; one study found that unilateral cranial 
autonomic symptoms occurred during migraine attacks 
in 81 patients (45.8%); during attacks, ocular 
symptoms (conjunctival injection, lacrimation, or eyelid 
edema) occurred alone in 33 patients and in 
combination with nasal symptoms (nasal stuffiness or 
rhinorrhea) in 37 patients. Isolated nasal symptoms 
occurred in 11 patients. Other studies from other 
populations have documented varying frequencies of 
these symptoms in migraine patients.10,12,24,25 
Mean age of our patients was 35 years however; very 
young age i-e; 19 years old patients were also included 
&nearly two third patients (62.86%, n=66) were of 
21-40 years. These findings do not match with other 
studies which is due to the fact that migraine is 
prevalent in all age groups & different studies focus 
different age groups11,18,21,26,.We had taken only 
the adult patients. Other demographic feature of our 
patients was the gender distribution. We noted that 
majority of patients were females i-e; 59% that agrees 
with findings of previous researchers 10,11,20,22But; 
in the current study, the stratified analysis significantly 
showed that the female patients had very higher 
incidence of CAS (77.4%) compared to their male 
counterparts (60.5%). (P value < 0.049).  Regarding 
age the stratified analysis significantly showed that 
middle aged (21-40 years) patients had higher 
frequency of cranial autonomic symptomscompared to 
elder and very younger age patients (P value = 
0.303).Living in a rural or urban setting was also 
doubted to be an effect modifier but the current study 
ruled out it and found that residence showed only 
minimal difference as the urban living patients had 
CAS incidence of 71.2%compared to 69.8% in rural 
patients. (P value = 0.525).One important aspect of 
this study was evaluation of duration of migraine since 
its diagnosis and look for its association with 
incidenceof cranial autonomic symptoms in our 
patients. We hereby document that it was a significant 
finding in our analysis that longer the duration of 
disease, higher was the frequency of CAS. (P value 
0.002). Studies have documented that the patients 
with unilateral cranial autonomic symptomspresent 
with more severe headaches (P value <0.0002) and 
more strictly unilateral headaches (P value <0.0004) 
than those without unilateral cranial autonomic 
symptoms, findings that suggest trigeminal-autonomic 
reflex activation.10 Apart from that it has been 
suggested that a general autonomic hyperactivity 
(especiallyparasympathetic) may also be found more 
frequent in different populations of CAS–positive 
migraineurscompared to  CAS negative 
migraineurs5,8,15 but exploring these was beyond the 
scope of the current study.Although the study was of 
limited scope due to limited financial & time resources 
and smaller sample size yet it has investigated an 
important aspect of clinical pictures of migraine 
patients. The study also found the magnitude of 
burden of cranial autonomic symptoms in such 
patients which previously had been a neglected issue 
in our part of world. The current study suggests that 
more in depth and larger studies should be conducted 
on this aspect of migraine.
 
CONCLUSION
It is evidence based fact that cranial autonomic 
symptoms (CAS) such as lacrimation, conjunctival 
injection, eyelid edema and nasal congestion, which 
are the hallmark of trigeminal autonomic cephalalgias 
may also occur in migraine patients. The current study 
evaluated the magnitude of burden of these symptoms 
in local migraine affected patients. The study found 
that the cranial autonomic symptomsin migraine 
patients are very frequently present. Forehead/ facial 
sweating, lacrimation, nasal congestion, conjunctival 
injection, rhinorrhea and eyelid edema were the 
commonest symptoms. Female gender, middle age, 
and longer duration of disease are associated with 
higher incidence of CAS. The study recommends that 
all migraine patients should be evaluated for cranial 
autonomic symptoms from the day one of their 
diagnosis.Failure to recognize CAS would lead to 
misdiagnosis or under diagnosis of a common 
treatable condition resulting in increment in patient’s 
misery. Its early recognition could have therapeutic 
implications, given the potential large scale 
recruitment of peripheral neurovascular 5-HT 1B/1D 
receptors (the target of acute migraine treatment) in 
such patients.
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INTRODUCTION
Of all the painful states that afflict humans, headache 
is undoubtedly the most frequent and common reason 
for seeking medical help. Headache has over 300 
different types and different etiologies; migraine is one 
of them and continues being an under diagnosed 
condition in many of cases as it can be accompanied 
by symptoms commonly associated with other causes 
of facial pain.  Out of 28 million people in USA who 
have history of headache and symptoms which mimic 
the typical migraine only 48% are diagnosed of 
migraine.  In Pakistan the prevalenceof migraine was 
found to be around 30%. ,  and about twice as 
frequently in women as in men5. Migraine headaches, 
which are often, misdiagnosed as sinus or tension 
headaches affects work, social and leisure activities & 
has tremendous impact on a person’s life 6 .WHO in 
2004 released a report placing migraine on 19th rank 
with which migraine sufferers live years of their life with 
disability. 7These may occur as often as several times 
per week oras rarely as once or twice a year8.Cranial 
autonomic symptoms (CAS) are typically associated 
with trigeminal autonomic cephalgias, such as cluster 
headache 9. However they may also occur in patients 
with migraine. The frequency of symptoms is reported 
to vary widely from 27% to 73% in different studies. 
10,11,12 Recognition of CAS as a common 
component of migraine is important diagnostically and 
thus therapeutically. In a study conducted on pediatric 
patients, nearly 40% 13 and in another study 
conducted on adult patients it was found that 52% 
were initially mislabeled as having sinus related 
headaches 14.The international Classification of 
Headache Disorders, second edition 
(ICHD-II)15includes conjuctival injection, lacrimation 
(or both), nasal congestion, rhinorrhea (or both), eyelid 
edema, forehead and facial sweating, forehead/facial 
flushing and/or miosis& ptosis .In ICHD-III, a sense of 
aural fullness will be added as a cranial autonomic 
symptom.16. The international studies have 
documented variability in prevalence of CAS among 
migraine patients however no study was done at local 
level. The current study has evaluated and measured 
the burden of CAS among migraine patients in tertiary 
care hospital. Failure to recognize which, may lead to 
unnecessary investigations and delaying appropriate 
migraine therapy.
MATERIAL AND METHODS
This was a descriptive cross sectional study carried out 
in Neurology department JinnahPostgraduate Medical 
Center, Karachi from 1stJanuary 2015 to 31stt 
December 2015. Estimated prevalence of CAS among 
migraine patients taken at rate of 15.6%12, margin of 
error 7%, & level of significance 95% and using WHO’s 
sample size calculator the calculated sample size 
came was 103 ~ 105.Non probability consecutive 
sampling technique was used to select 
sample.Informed consent was taken from the patients 
and purpose of study was explained to them. 
Diagnosed cases of migraine for at least >1 year, of 
either gender with age between 18 to 60 years and 
ready to participate in the study were included.Patients 
fulfilling criteria for Trigeminal autonomic cephalalgias, 
tension type headache, head injury, bell’s palsy, space 
occupying lesion of brain ,patients suffering from 
autonomic neuropathy due to diabetes mellitus, , 
glaucoma, uveitis, recent ophthalmological and ENT 
surgery andpatients having symptoms of allergic 
rhinitisand nasal obstructive symptoms were excluded 
from the study.Permission for the data collection was 
taken from Ethical committee of JPMC.The researcher 
collected data on a predesigned pro forma including 
demographic variables like name, age, gender 
andresidence,further data regarding presence of CAS 
(conjuctival injection, lacrimation, nasal congestion, 
rhinorrhea, eyelid edema, forehead/facial sweating, 
forehead/facial flushing and miosis or ptosis) were also 
collected.The data entry and analysis was done using 
SPSS version 19. Mean ± SD was expressed for 
continuous variable like age, duration of disease & 
duration of migraine attack. Frequency & percentages 
were expressed for gender & residence (rural or urban), 
number of attacks of migraine & presence of CAS. The 
effect modification of outcome variable (frequency of 
CAS) due to age, gender, & duration of diseasewere 
analyzed by stratification of these variables followed by 
application of the chi-Square test with a P value 
significance of <0.05. Selection criteria were strictly 
followed to control for the potential confounders.
 
RESULTS
The current study assessed the frequency of cranial 
autonomic symptoms among migraine headache 
patients. Mean ± SD age of patients was 35.08 ± 
10.18 years with a range from 19-60 years. Mean ± 
SD duration of migraineat time of presentation was 
3.68 ± 1.42 years & minimum & maximum durations 
were 01 &05years respectively. (Table1). 
Table: 1. Basic characteristics. (n= 105)
Further it was noted that mean ± SD duration of 
attack of migraine headache was 25.14 ± 9.89 hours 
with the range of 4 to 72 hours. (Table1).It was 
observed that nearly two third of the patients (62.86%, 
n=66) were of 21-40 years of age, (29.52%, n = 31) 
were of age 41-60 years while remaining 7.62% (n= 
8) were of age upto 20 years. Majority of patients were 
females i-e; 59% (n=62).Equal distribution was noted 
as far as residence was concerned. Urban residents 
were 49.5% (n= 52).Majority of patients (62.9%, 
n=66) had history of migraine for 4-5 years, other 
21%, (n= 22) had migraine for 2-3 years while only 
16.2% (n= 17) patients presented with upto 1 year 
history of migraine.Frequency of cranial autonomic 
symptoms (CAS) in migraine patients (the primary 
outcome) were detected among 70.48% (n= 74 out 
of 105). (Figure1) and forehead/facial sweating was 
most common symptom. (Table:2)
Figure: 1. Frequency of cranial autonomic symptoms 
in Migraine patients. (n=105)
Table: 2. Frequency of different cranial autonomic 
symptoms.
To evaluate the effect modification of outcome variable 
by other variables we conducted the stratified analysis. 
It was found in this analysis that frequency of cranial 
autonomic symptoms (CAS) was more (75.8%) in 
patients of 21-40 years age compared to elder and 
very younger age patients (i-e; 61.3% in 41-60 years 
age group &62.5% in upto 20 years age group). (P 
value = 0.303; Table: 3).
Table: 3 Effect of age on frequency cranial autonomic 
symptoms in Migraine patients.
It was significantly noted that female patients had very 
higher incidence of CAS (77.4%) compared to their 
male counterparts (60.5%). (P value < 0.049; Table: 
4).
Table: 4. Effect of genderon frequency cranial 
autonomic symptoms in Migraine patients.
Residence showed only minimal difference and urban 
patients had 71.2%frequency of CAS compared to 
69.8% among rural patients. (P value 
0.525).However; it was worth noting that longer the 
duration of disease, higher was the frequency of 
cranial autonomic symptoms (CAS) and the finding 
was significant. (P value 0.002). The frequency of CAS 
was 58.82% among patients with history of upto 1 
year duration of migraine, 68.18% among patient with 
history of 2-3 years&74.24% among 4-5 years history 
of migraine.
DISCUSSION
Migraineis a common and disablingneurological 
disorder.17,18.Daily many patients in our neurology 
OPD present with episodic severe throbbing headache 
which is diagnosed as migraine. It is characterized by 
recurrent attacks of headache and combinations of 
neurologic, gastrointestinal, and autonomic changes. 
Unilateral cranial autonomic symptoms (UAS) are 
features of cluster headache, paroxysmal hemicrania, 
and SUNCT.2,9,12,17Studies have found an 
association between cranial autonomic symptoms and 
migraineattack, hypothesizing possiblepathogenesis 
10,12,19.On the basis of these considerations 
andonsuggestionofacranial parasympathetic activation 
in some migraineurs, we evaluated the frequency of 
cranial autonomic symptoms during cephalalgic 
attacks in patients presenting to our institute with the 
symptoms of migraine.Our study shows that in 
migraineurs, cranial autonomic symptoms are 
common. It was found that incidence of cranial 
autonomic symptoms (CAS) in migraine patients was 
70.48%.Our results are correlating with similar results 
of other studies. However; the incidence of CAS 
reported by various studies range from 27% to 
Duration of disease Frequency Percentage 
Forehead/ facial
sweating
 43 41 
Lacrimation 33 31.4 
Nasal congestion 26 24.8 
Conjunctival injection 23 21.9 
Rhinorrhea 22 21 
Eyelid edema 17 16.2 
 
Age of the Patient 
Cranial Autonomic 
Symptoms 
Total P value 
Yes No 
Upto 20 Years 
5 3 8 
0.303 
62.5% 37.5% 100.0% 
21-40 Years 
50 16 66 
75.8% 24.2% 100.0% 
41-60 Years 
19 12 31 
61.3% 38.7% 100.0% 
Total 
74 31 105 
70.5% 29.5% 100.0% 
 
Gender 
Cranial Autonomic 
Symptoms 
Total P value 
Yes No 
Female 
48 14 62 
0.049 
77.4% 22.6% 100.0% 
Male 
26 17 43 
60.5% 39.5% 100.0% 
Total 
74 31 105 
70.5% 29.5% 100.0% 
 
73%7,10,12,20,21,22. Our study did not include the 
pediatric patients. But in a recentstudy23high 
frequency of cranial autonomic symptoms was found in 
pediatric migraineurs(i-e; 62%, which canrise to 
70%with inclusion of new proposed International 
Headache Society criteria)16. We have not used the 
new proposed International Headache Society criteria 
otherwise the incidence rate might have been found at 
least 10% more.In a prospective study conducted on 
migraine patients, the prevalence of >1 CAS was 
56%17. Likewise; in the current study we noted that 
about 52% patients had >1 CAS e.g; forehead/ facial 
sweating, lacrimation, nasal congestion, conjunctival 
injection, rhinorrhea, and eyelid edema. Presence of 
more than one CAS in migraine patients clearly directs 
its association with cranial autonomic symptoms. Lai 
TH, et al., reported that among migraine patients with 
CAS, forehead/ facial sweating was the most common 
(51.7%) followed by lacrimation (44.2%), nasal 
congestion (25.2%), conjunctival injection (23.8%), 
rhinorrhea (21.5%), and eyelid edema (15.6%)9.The 
current study found very similar pattern but the 
incidence of these symptoms was lesser. Accordingly; 
forehead/ facial sweating was the most common 
(41%) followed by lacrimation (31.4%), nasal 
congestion (24.8%), conjunctival injection (21.9%). 
Similarly; one study found that unilateral cranial 
autonomic symptoms occurred during migraine attacks 
in 81 patients (45.8%); during attacks, ocular 
symptoms (conjunctival injection, lacrimation, or eyelid 
edema) occurred alone in 33 patients and in 
combination with nasal symptoms (nasal stuffiness or 
rhinorrhea) in 37 patients. Isolated nasal symptoms 
occurred in 11 patients. Other studies from other 
populations have documented varying frequencies of 
these symptoms in migraine patients.10,12,24,25 
Mean age of our patients was 35 years however; very 
young age i-e; 19 years old patients were also included 
&nearly two third patients (62.86%, n=66) were of 
21-40 years. These findings do not match with other 
studies which is due to the fact that migraine is 
prevalent in all age groups & different studies focus 
different age groups11,18,21,26,.We had taken only 
the adult patients. Other demographic feature of our 
patients was the gender distribution. We noted that 
majority of patients were females i-e; 59% that agrees 
with findings of previous researchers 10,11,20,22But; 
in the current study, the stratified analysis significantly 
showed that the female patients had very higher 
incidence of CAS (77.4%) compared to their male 
counterparts (60.5%). (P value < 0.049).  Regarding 
age the stratified analysis significantly showed that 
middle aged (21-40 years) patients had higher 
frequency of cranial autonomic symptomscompared to 
elder and very younger age patients (P value = 
0.303).Living in a rural or urban setting was also 
doubted to be an effect modifier but the current study 
ruled out it and found that residence showed only 
minimal difference as the urban living patients had 
CAS incidence of 71.2%compared to 69.8% in rural 
patients. (P value = 0.525).One important aspect of 
this study was evaluation of duration of migraine since 
its diagnosis and look for its association with 
incidenceof cranial autonomic symptoms in our 
patients. We hereby document that it was a significant 
finding in our analysis that longer the duration of 
disease, higher was the frequency of CAS. (P value 
0.002). Studies have documented that the patients 
with unilateral cranial autonomic symptomspresent 
with more severe headaches (P value <0.0002) and 
more strictly unilateral headaches (P value <0.0004) 
than those without unilateral cranial autonomic 
symptoms, findings that suggest trigeminal-autonomic 
reflex activation.10 Apart from that it has been 
suggested that a general autonomic hyperactivity 
(especiallyparasympathetic) may also be found more 
frequent in different populations of CAS–positive 
migraineurscompared to  CAS negative 
migraineurs5,8,15 but exploring these was beyond the 
scope of the current study.Although the study was of 
limited scope due to limited financial & time resources 
and smaller sample size yet it has investigated an 
important aspect of clinical pictures of migraine 
patients. The study also found the magnitude of 
burden of cranial autonomic symptoms in such 
patients which previously had been a neglected issue 
in our part of world. The current study suggests that 
more in depth and larger studies should be conducted 
on this aspect of migraine.
 
CONCLUSION
It is evidence based fact that cranial autonomic 
symptoms (CAS) such as lacrimation, conjunctival 
injection, eyelid edema and nasal congestion, which 
are the hallmark of trigeminal autonomic cephalalgias 
may also occur in migraine patients. The current study 
evaluated the magnitude of burden of these symptoms 
in local migraine affected patients. The study found 
that the cranial autonomic symptomsin migraine 
patients are very frequently present. Forehead/ facial 
sweating, lacrimation, nasal congestion, conjunctival 
injection, rhinorrhea and eyelid edema were the 
commonest symptoms. Female gender, middle age, 
and longer duration of disease are associated with 
higher incidence of CAS. The study recommends that 
all migraine patients should be evaluated for cranial 
autonomic symptoms from the day one of their 
diagnosis.Failure to recognize CAS would lead to 
misdiagnosis or under diagnosis of a common 
treatable condition resulting in increment in patient’s 
misery. Its early recognition could have therapeutic 
implications, given the potential large scale 
recruitment of peripheral neurovascular 5-HT 1B/1D 
receptors (the target of acute migraine treatment) in 
such patients.
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INTRODUCTION
Of all the painful states that afflict humans, headache 
is undoubtedly the most frequent and common reason 
for seeking medical help. Headache has over 300 
different types and different etiologies; migraine is one 
of them and continues being an under diagnosed 
condition in many of cases as it can be accompanied 
by symptoms commonly associated with other causes 
of facial pain.  Out of 28 million people in USA who 
have history of headache and symptoms which mimic 
the typical migraine only 48% are diagnosed of 
migraine.  In Pakistan the prevalenceof migraine was 
found to be around 30%. ,  and about twice as 
frequently in women as in men5. Migraine headaches, 
which are often, misdiagnosed as sinus or tension 
headaches affects work, social and leisure activities & 
has tremendous impact on a person’s life 6 .WHO in 
2004 released a report placing migraine on 19th rank 
with which migraine sufferers live years of their life with 
disability. 7These may occur as often as several times 
per week oras rarely as once or twice a year8.Cranial 
autonomic symptoms (CAS) are typically associated 
with trigeminal autonomic cephalgias, such as cluster 
headache 9. However they may also occur in patients 
with migraine. The frequency of symptoms is reported 
to vary widely from 27% to 73% in different studies. 
10,11,12 Recognition of CAS as a common 
component of migraine is important diagnostically and 
thus therapeutically. In a study conducted on pediatric 
patients, nearly 40% 13 and in another study 
conducted on adult patients it was found that 52% 
were initially mislabeled as having sinus related 
headaches 14.The international Classification of 
Headache Disorders, second edition 
(ICHD-II)15includes conjuctival injection, lacrimation 
(or both), nasal congestion, rhinorrhea (or both), eyelid 
edema, forehead and facial sweating, forehead/facial 
flushing and/or miosis& ptosis .In ICHD-III, a sense of 
aural fullness will be added as a cranial autonomic 
symptom.16. The international studies have 
documented variability in prevalence of CAS among 
migraine patients however no study was done at local 
level. The current study has evaluated and measured 
the burden of CAS among migraine patients in tertiary 
care hospital. Failure to recognize which, may lead to 
unnecessary investigations and delaying appropriate 
migraine therapy.
MATERIAL AND METHODS
This was a descriptive cross sectional study carried out 
in Neurology department JinnahPostgraduate Medical 
Center, Karachi from 1stJanuary 2015 to 31stt 
December 2015. Estimated prevalence of CAS among 
migraine patients taken at rate of 15.6%12, margin of 
error 7%, & level of significance 95% and using WHO’s 
sample size calculator the calculated sample size 
came was 103 ~ 105.Non probability consecutive 
sampling technique was used to select 
sample.Informed consent was taken from the patients 
and purpose of study was explained to them. 
Diagnosed cases of migraine for at least >1 year, of 
either gender with age between 18 to 60 years and 
ready to participate in the study were included.Patients 
fulfilling criteria for Trigeminal autonomic cephalalgias, 
tension type headache, head injury, bell’s palsy, space 
occupying lesion of brain ,patients suffering from 
autonomic neuropathy due to diabetes mellitus, , 
glaucoma, uveitis, recent ophthalmological and ENT 
surgery andpatients having symptoms of allergic 
rhinitisand nasal obstructive symptoms were excluded 
from the study.Permission for the data collection was 
taken from Ethical committee of JPMC.The researcher 
collected data on a predesigned pro forma including 
demographic variables like name, age, gender 
andresidence,further data regarding presence of CAS 
(conjuctival injection, lacrimation, nasal congestion, 
rhinorrhea, eyelid edema, forehead/facial sweating, 
forehead/facial flushing and miosis or ptosis) were also 
collected.The data entry and analysis was done using 
SPSS version 19. Mean ± SD was expressed for 
continuous variable like age, duration of disease & 
duration of migraine attack. Frequency & percentages 
were expressed for gender & residence (rural or urban), 
number of attacks of migraine & presence of CAS. The 
effect modification of outcome variable (frequency of 
CAS) due to age, gender, & duration of diseasewere 
analyzed by stratification of these variables followed by 
application of the chi-Square test with a P value 
significance of <0.05. Selection criteria were strictly 
followed to control for the potential confounders.
 
RESULTS
The current study assessed the frequency of cranial 
autonomic symptoms among migraine headache 
patients. Mean ± SD age of patients was 35.08 ± 
10.18 years with a range from 19-60 years. Mean ± 
SD duration of migraineat time of presentation was 
3.68 ± 1.42 years & minimum & maximum durations 
were 01 &05years respectively. (Table1). 
Table: 1. Basic characteristics. (n= 105)
Further it was noted that mean ± SD duration of 
attack of migraine headache was 25.14 ± 9.89 hours 
with the range of 4 to 72 hours. (Table1).It was 
observed that nearly two third of the patients (62.86%, 
n=66) were of 21-40 years of age, (29.52%, n = 31) 
were of age 41-60 years while remaining 7.62% (n= 
8) were of age upto 20 years. Majority of patients were 
females i-e; 59% (n=62).Equal distribution was noted 
as far as residence was concerned. Urban residents 
were 49.5% (n= 52).Majority of patients (62.9%, 
n=66) had history of migraine for 4-5 years, other 
21%, (n= 22) had migraine for 2-3 years while only 
16.2% (n= 17) patients presented with upto 1 year 
history of migraine.Frequency of cranial autonomic 
symptoms (CAS) in migraine patients (the primary 
outcome) were detected among 70.48% (n= 74 out 
of 105). (Figure1) and forehead/facial sweating was 
most common symptom. (Table:2)
Figure: 1. Frequency of cranial autonomic symptoms 
in Migraine patients. (n=105)
Table: 2. Frequency of different cranial autonomic 
symptoms.
To evaluate the effect modification of outcome variable 
by other variables we conducted the stratified analysis. 
It was found in this analysis that frequency of cranial 
autonomic symptoms (CAS) was more (75.8%) in 
patients of 21-40 years age compared to elder and 
very younger age patients (i-e; 61.3% in 41-60 years 
age group &62.5% in upto 20 years age group). (P 
value = 0.303; Table: 3).
Table: 3 Effect of age on frequency cranial autonomic 
symptoms in Migraine patients.
It was significantly noted that female patients had very 
higher incidence of CAS (77.4%) compared to their 
male counterparts (60.5%). (P value < 0.049; Table: 
4).
Table: 4. Effect of genderon frequency cranial 
autonomic symptoms in Migraine patients.
Residence showed only minimal difference and urban 
patients had 71.2%frequency of CAS compared to 
69.8% among rural patients. (P value 
0.525).However; it was worth noting that longer the 
duration of disease, higher was the frequency of 
cranial autonomic symptoms (CAS) and the finding 
was significant. (P value 0.002). The frequency of CAS 
was 58.82% among patients with history of upto 1 
year duration of migraine, 68.18% among patient with 
history of 2-3 years&74.24% among 4-5 years history 
of migraine.
DISCUSSION
Migraineis a common and disablingneurological 
disorder.17,18.Daily many patients in our neurology 
OPD present with episodic severe throbbing headache 
which is diagnosed as migraine. It is characterized by 
recurrent attacks of headache and combinations of 
neurologic, gastrointestinal, and autonomic changes. 
Unilateral cranial autonomic symptoms (UAS) are 
features of cluster headache, paroxysmal hemicrania, 
and SUNCT.2,9,12,17Studies have found an 
association between cranial autonomic symptoms and 
migraineattack, hypothesizing possiblepathogenesis 
10,12,19.On the basis of these considerations 
andonsuggestionofacranial parasympathetic activation 
in some migraineurs, we evaluated the frequency of 
cranial autonomic symptoms during cephalalgic 
attacks in patients presenting to our institute with the 
symptoms of migraine.Our study shows that in 
migraineurs, cranial autonomic symptoms are 
common. It was found that incidence of cranial 
autonomic symptoms (CAS) in migraine patients was 
70.48%.Our results are correlating with similar results 
of other studies. However; the incidence of CAS 
reported by various studies range from 27% to 
73%7,10,12,20,21,22. Our study did not include the 
pediatric patients. But in a recentstudy23high 
frequency of cranial autonomic symptoms was found in 
pediatric migraineurs(i-e; 62%, which canrise to 
70%with inclusion of new proposed International 
Headache Society criteria)16. We have not used the 
new proposed International Headache Society criteria 
otherwise the incidence rate might have been found at 
least 10% more.In a prospective study conducted on 
migraine patients, the prevalence of >1 CAS was 
56%17. Likewise; in the current study we noted that 
about 52% patients had >1 CAS e.g; forehead/ facial 
sweating, lacrimation, nasal congestion, conjunctival 
injection, rhinorrhea, and eyelid edema. Presence of 
more than one CAS in migraine patients clearly directs 
its association with cranial autonomic symptoms. Lai 
TH, et al., reported that among migraine patients with 
CAS, forehead/ facial sweating was the most common 
(51.7%) followed by lacrimation (44.2%), nasal 
congestion (25.2%), conjunctival injection (23.8%), 
rhinorrhea (21.5%), and eyelid edema (15.6%)9.The 
current study found very similar pattern but the 
incidence of these symptoms was lesser. Accordingly; 
forehead/ facial sweating was the most common 
(41%) followed by lacrimation (31.4%), nasal 
congestion (24.8%), conjunctival injection (21.9%). 
Similarly; one study found that unilateral cranial 
autonomic symptoms occurred during migraine attacks 
in 81 patients (45.8%); during attacks, ocular 
symptoms (conjunctival injection, lacrimation, or eyelid 
edema) occurred alone in 33 patients and in 
combination with nasal symptoms (nasal stuffiness or 
rhinorrhea) in 37 patients. Isolated nasal symptoms 
occurred in 11 patients. Other studies from other 
populations have documented varying frequencies of 
these symptoms in migraine patients.10,12,24,25 
Mean age of our patients was 35 years however; very 
young age i-e; 19 years old patients were also included 
&nearly two third patients (62.86%, n=66) were of 
21-40 years. These findings do not match with other 
studies which is due to the fact that migraine is 
prevalent in all age groups & different studies focus 
different age groups11,18,21,26,.We had taken only 
the adult patients. Other demographic feature of our 
patients was the gender distribution. We noted that 
majority of patients were females i-e; 59% that agrees 
with findings of previous researchers 10,11,20,22But; 
in the current study, the stratified analysis significantly 
showed that the female patients had very higher 
incidence of CAS (77.4%) compared to their male 
counterparts (60.5%). (P value < 0.049).  Regarding 
age the stratified analysis significantly showed that 
middle aged (21-40 years) patients had higher 
frequency of cranial autonomic symptomscompared to 
elder and very younger age patients (P value = 
0.303).Living in a rural or urban setting was also 
doubted to be an effect modifier but the current study 
ruled out it and found that residence showed only 
minimal difference as the urban living patients had 
CAS incidence of 71.2%compared to 69.8% in rural 
patients. (P value = 0.525).One important aspect of 
this study was evaluation of duration of migraine since 
its diagnosis and look for its association with 
incidenceof cranial autonomic symptoms in our 
patients. We hereby document that it was a significant 
finding in our analysis that longer the duration of 
disease, higher was the frequency of CAS. (P value 
0.002). Studies have documented that the patients 
with unilateral cranial autonomic symptomspresent 
with more severe headaches (P value <0.0002) and 
more strictly unilateral headaches (P value <0.0004) 
than those without unilateral cranial autonomic 
symptoms, findings that suggest trigeminal-autonomic 
reflex activation.10 Apart from that it has been 
suggested that a general autonomic hyperactivity 
(especiallyparasympathetic) may also be found more 
frequent in different populations of CAS–positive 
migraineurscompared to  CAS negative 
migraineurs5,8,15 but exploring these was beyond the 
scope of the current study.Although the study was of 
limited scope due to limited financial & time resources 
and smaller sample size yet it has investigated an 
important aspect of clinical pictures of migraine 
patients. The study also found the magnitude of 
burden of cranial autonomic symptoms in such 
patients which previously had been a neglected issue 
in our part of world. The current study suggests that 
more in depth and larger studies should be conducted 
on this aspect of migraine.
 
CONCLUSION
It is evidence based fact that cranial autonomic 
symptoms (CAS) such as lacrimation, conjunctival 
injection, eyelid edema and nasal congestion, which 
are the hallmark of trigeminal autonomic cephalalgias 
may also occur in migraine patients. The current study 
evaluated the magnitude of burden of these symptoms 
in local migraine affected patients. The study found 
that the cranial autonomic symptomsin migraine 
patients are very frequently present. Forehead/ facial 
sweating, lacrimation, nasal congestion, conjunctival 
injection, rhinorrhea and eyelid edema were the 
commonest symptoms. Female gender, middle age, 
and longer duration of disease are associated with 
higher incidence of CAS. The study recommends that 
all migraine patients should be evaluated for cranial 
autonomic symptoms from the day one of their 
diagnosis.Failure to recognize CAS would lead to 
misdiagnosis or under diagnosis of a common 
treatable condition resulting in increment in patient’s 
misery. Its early recognition could have therapeutic 
implications, given the potential large scale 
recruitment of peripheral neurovascular 5-HT 1B/1D 
receptors (the target of acute migraine treatment) in 
such patients.
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INTRODUCTION
Of all the painful states that afflict humans, headache 
is undoubtedly the most frequent and common reason 
for seeking medical help. Headache has over 300 
different types and different etiologies; migraine is one 
of them and continues being an under diagnosed 
condition in many of cases as it can be accompanied 
by symptoms commonly associated with other causes 
of facial pain.  Out of 28 million people in USA who 
have history of headache and symptoms which mimic 
the typical migraine only 48% are diagnosed of 
migraine.  In Pakistan the prevalenceof migraine was 
found to be around 30%. ,  and about twice as 
frequently in women as in men5. Migraine headaches, 
which are often, misdiagnosed as sinus or tension 
headaches affects work, social and leisure activities & 
has tremendous impact on a person’s life 6 .WHO in 
2004 released a report placing migraine on 19th rank 
with which migraine sufferers live years of their life with 
disability. 7These may occur as often as several times 
per week oras rarely as once or twice a year8.Cranial 
autonomic symptoms (CAS) are typically associated 
with trigeminal autonomic cephalgias, such as cluster 
headache 9. However they may also occur in patients 
with migraine. The frequency of symptoms is reported 
to vary widely from 27% to 73% in different studies. 
10,11,12 Recognition of CAS as a common 
component of migraine is important diagnostically and 
thus therapeutically. In a study conducted on pediatric 
patients, nearly 40% 13 and in another study 
conducted on adult patients it was found that 52% 
were initially mislabeled as having sinus related 
headaches 14.The international Classification of 
Headache Disorders, second edition 
(ICHD-II)15includes conjuctival injection, lacrimation 
(or both), nasal congestion, rhinorrhea (or both), eyelid 
edema, forehead and facial sweating, forehead/facial 
flushing and/or miosis& ptosis .In ICHD-III, a sense of 
aural fullness will be added as a cranial autonomic 
symptom.16. The international studies have 
documented variability in prevalence of CAS among 
migraine patients however no study was done at local 
level. The current study has evaluated and measured 
the burden of CAS among migraine patients in tertiary 
care hospital. Failure to recognize which, may lead to 
unnecessary investigations and delaying appropriate 
migraine therapy.
MATERIAL AND METHODS
This was a descriptive cross sectional study carried out 
in Neurology department JinnahPostgraduate Medical 
Center, Karachi from 1stJanuary 2015 to 31stt 
December 2015. Estimated prevalence of CAS among 
migraine patients taken at rate of 15.6%12, margin of 
error 7%, & level of significance 95% and using WHO’s 
sample size calculator the calculated sample size 
came was 103 ~ 105.Non probability consecutive 
sampling technique was used to select 
sample.Informed consent was taken from the patients 
and purpose of study was explained to them. 
Diagnosed cases of migraine for at least >1 year, of 
either gender with age between 18 to 60 years and 
ready to participate in the study were included.Patients 
fulfilling criteria for Trigeminal autonomic cephalalgias, 
tension type headache, head injury, bell’s palsy, space 
occupying lesion of brain ,patients suffering from 
autonomic neuropathy due to diabetes mellitus, , 
glaucoma, uveitis, recent ophthalmological and ENT 
surgery andpatients having symptoms of allergic 
rhinitisand nasal obstructive symptoms were excluded 
from the study.Permission for the data collection was 
taken from Ethical committee of JPMC.The researcher 
collected data on a predesigned pro forma including 
demographic variables like name, age, gender 
andresidence,further data regarding presence of CAS 
(conjuctival injection, lacrimation, nasal congestion, 
rhinorrhea, eyelid edema, forehead/facial sweating, 
forehead/facial flushing and miosis or ptosis) were also 
collected.The data entry and analysis was done using 
SPSS version 19. Mean ± SD was expressed for 
continuous variable like age, duration of disease & 
duration of migraine attack. Frequency & percentages 
were expressed for gender & residence (rural or urban), 
number of attacks of migraine & presence of CAS. The 
effect modification of outcome variable (frequency of 
CAS) due to age, gender, & duration of diseasewere 
analyzed by stratification of these variables followed by 
application of the chi-Square test with a P value 
significance of <0.05. Selection criteria were strictly 
followed to control for the potential confounders.
 
RESULTS
The current study assessed the frequency of cranial 
autonomic symptoms among migraine headache 
patients. Mean ± SD age of patients was 35.08 ± 
10.18 years with a range from 19-60 years. Mean ± 
SD duration of migraineat time of presentation was 
3.68 ± 1.42 years & minimum & maximum durations 
were 01 &05years respectively. (Table1). 
Table: 1. Basic characteristics. (n= 105)
Further it was noted that mean ± SD duration of 
attack of migraine headache was 25.14 ± 9.89 hours 
with the range of 4 to 72 hours. (Table1).It was 
observed that nearly two third of the patients (62.86%, 
n=66) were of 21-40 years of age, (29.52%, n = 31) 
were of age 41-60 years while remaining 7.62% (n= 
8) were of age upto 20 years. Majority of patients were 
females i-e; 59% (n=62).Equal distribution was noted 
as far as residence was concerned. Urban residents 
were 49.5% (n= 52).Majority of patients (62.9%, 
n=66) had history of migraine for 4-5 years, other 
21%, (n= 22) had migraine for 2-3 years while only 
16.2% (n= 17) patients presented with upto 1 year 
history of migraine.Frequency of cranial autonomic 
symptoms (CAS) in migraine patients (the primary 
outcome) were detected among 70.48% (n= 74 out 
of 105). (Figure1) and forehead/facial sweating was 
most common symptom. (Table:2)
Figure: 1. Frequency of cranial autonomic symptoms 
in Migraine patients. (n=105)
Table: 2. Frequency of different cranial autonomic 
symptoms.
To evaluate the effect modification of outcome variable 
by other variables we conducted the stratified analysis. 
It was found in this analysis that frequency of cranial 
autonomic symptoms (CAS) was more (75.8%) in 
patients of 21-40 years age compared to elder and 
very younger age patients (i-e; 61.3% in 41-60 years 
age group &62.5% in upto 20 years age group). (P 
value = 0.303; Table: 3).
Table: 3 Effect of age on frequency cranial autonomic 
symptoms in Migraine patients.
It was significantly noted that female patients had very 
higher incidence of CAS (77.4%) compared to their 
male counterparts (60.5%). (P value < 0.049; Table: 
4).
Table: 4. Effect of genderon frequency cranial 
autonomic symptoms in Migraine patients.
Residence showed only minimal difference and urban 
patients had 71.2%frequency of CAS compared to 
69.8% among rural patients. (P value 
0.525).However; it was worth noting that longer the 
duration of disease, higher was the frequency of 
cranial autonomic symptoms (CAS) and the finding 
was significant. (P value 0.002). The frequency of CAS 
was 58.82% among patients with history of upto 1 
year duration of migraine, 68.18% among patient with 
history of 2-3 years&74.24% among 4-5 years history 
of migraine.
DISCUSSION
Migraineis a common and disablingneurological 
disorder.17,18.Daily many patients in our neurology 
OPD present with episodic severe throbbing headache 
which is diagnosed as migraine. It is characterized by 
recurrent attacks of headache and combinations of 
neurologic, gastrointestinal, and autonomic changes. 
Unilateral cranial autonomic symptoms (UAS) are 
features of cluster headache, paroxysmal hemicrania, 
and SUNCT.2,9,12,17Studies have found an 
association between cranial autonomic symptoms and 
migraineattack, hypothesizing possiblepathogenesis 
10,12,19.On the basis of these considerations 
andonsuggestionofacranial parasympathetic activation 
in some migraineurs, we evaluated the frequency of 
cranial autonomic symptoms during cephalalgic 
attacks in patients presenting to our institute with the 
symptoms of migraine.Our study shows that in 
migraineurs, cranial autonomic symptoms are 
common. It was found that incidence of cranial 
autonomic symptoms (CAS) in migraine patients was 
70.48%.Our results are correlating with similar results 
of other studies. However; the incidence of CAS 
reported by various studies range from 27% to 
73%7,10,12,20,21,22. Our study did not include the 
pediatric patients. But in a recentstudy23high 
frequency of cranial autonomic symptoms was found in 
pediatric migraineurs(i-e; 62%, which canrise to 
70%with inclusion of new proposed International 
Headache Society criteria)16. We have not used the 
new proposed International Headache Society criteria 
otherwise the incidence rate might have been found at 
least 10% more.In a prospective study conducted on 
migraine patients, the prevalence of >1 CAS was 
56%17. Likewise; in the current study we noted that 
about 52% patients had >1 CAS e.g; forehead/ facial 
sweating, lacrimation, nasal congestion, conjunctival 
injection, rhinorrhea, and eyelid edema. Presence of 
more than one CAS in migraine patients clearly directs 
its association with cranial autonomic symptoms. Lai 
TH, et al., reported that among migraine patients with 
CAS, forehead/ facial sweating was the most common 
(51.7%) followed by lacrimation (44.2%), nasal 
congestion (25.2%), conjunctival injection (23.8%), 
rhinorrhea (21.5%), and eyelid edema (15.6%)9.The 
current study found very similar pattern but the 
incidence of these symptoms was lesser. Accordingly; 
forehead/ facial sweating was the most common 
(41%) followed by lacrimation (31.4%), nasal 
congestion (24.8%), conjunctival injection (21.9%). 
Similarly; one study found that unilateral cranial 
autonomic symptoms occurred during migraine attacks 
in 81 patients (45.8%); during attacks, ocular 
symptoms (conjunctival injection, lacrimation, or eyelid 
edema) occurred alone in 33 patients and in 
combination with nasal symptoms (nasal stuffiness or 
rhinorrhea) in 37 patients. Isolated nasal symptoms 
occurred in 11 patients. Other studies from other 
populations have documented varying frequencies of 
these symptoms in migraine patients.10,12,24,25 
Mean age of our patients was 35 years however; very 
young age i-e; 19 years old patients were also included 
&nearly two third patients (62.86%, n=66) were of 
21-40 years. These findings do not match with other 
studies which is due to the fact that migraine is 
prevalent in all age groups & different studies focus 
different age groups11,18,21,26,.We had taken only 
the adult patients. Other demographic feature of our 
patients was the gender distribution. We noted that 
majority of patients were females i-e; 59% that agrees 
with findings of previous researchers 10,11,20,22But; 
in the current study, the stratified analysis significantly 
showed that the female patients had very higher 
incidence of CAS (77.4%) compared to their male 
counterparts (60.5%). (P value < 0.049).  Regarding 
age the stratified analysis significantly showed that 
middle aged (21-40 years) patients had higher 
frequency of cranial autonomic symptomscompared to 
elder and very younger age patients (P value = 
0.303).Living in a rural or urban setting was also 
doubted to be an effect modifier but the current study 
ruled out it and found that residence showed only 
minimal difference as the urban living patients had 
CAS incidence of 71.2%compared to 69.8% in rural 
patients. (P value = 0.525).One important aspect of 
this study was evaluation of duration of migraine since 
its diagnosis and look for its association with 
incidenceof cranial autonomic symptoms in our 
patients. We hereby document that it was a significant 
finding in our analysis that longer the duration of 
disease, higher was the frequency of CAS. (P value 
0.002). Studies have documented that the patients 
with unilateral cranial autonomic symptomspresent 
with more severe headaches (P value <0.0002) and 
more strictly unilateral headaches (P value <0.0004) 
than those without unilateral cranial autonomic 
symptoms, findings that suggest trigeminal-autonomic 
reflex activation.10 Apart from that it has been 
suggested that a general autonomic hyperactivity 
(especiallyparasympathetic) may also be found more 
frequent in different populations of CAS–positive 
migraineurscompared to  CAS negative 
migraineurs5,8,15 but exploring these was beyond the 
scope of the current study.Although the study was of 
limited scope due to limited financial & time resources 
and smaller sample size yet it has investigated an 
important aspect of clinical pictures of migraine 
patients. The study also found the magnitude of 
burden of cranial autonomic symptoms in such 
patients which previously had been a neglected issue 
in our part of world. The current study suggests that 
more in depth and larger studies should be conducted 
on this aspect of migraine.
 
CONCLUSION
It is evidence based fact that cranial autonomic 
symptoms (CAS) such as lacrimation, conjunctival 
injection, eyelid edema and nasal congestion, which 
are the hallmark of trigeminal autonomic cephalalgias 
may also occur in migraine patients. The current study 
evaluated the magnitude of burden of these symptoms 
in local migraine affected patients. The study found 
that the cranial autonomic symptomsin migraine 
patients are very frequently present. Forehead/ facial 
sweating, lacrimation, nasal congestion, conjunctival 
injection, rhinorrhea and eyelid edema were the 
commonest symptoms. Female gender, middle age, 
and longer duration of disease are associated with 
higher incidence of CAS. The study recommends that 
all migraine patients should be evaluated for cranial 
autonomic symptoms from the day one of their 
diagnosis.Failure to recognize CAS would lead to 
misdiagnosis or under diagnosis of a common 
treatable condition resulting in increment in patient’s 
misery. Its early recognition could have therapeutic 
implications, given the potential large scale 
recruitment of peripheral neurovascular 5-HT 1B/1D 
receptors (the target of acute migraine treatment) in 
such patients.
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